Differential response between the p53 ubiquitin–protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells
- 15 October 2006
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 312 (17) , 3370-3378
- https://doi.org/10.1016/j.yexcr.2006.07.005
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A new human gene hNTKL-BP1 interacts with hPirh2Biochemical and Biophysical Research Communications, 2005
- Expression of Pirh2, a Newly Identified Ubiquitin Protein Ligase, in Lung CancerJNCI Journal of the National Cancer Institute, 2004
- COP1, the Negative Regulator of p53, Is Overexpressed in Breast and Ovarian AdenocarcinomasCancer Research, 2004
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004
- Control of Human PIRH2 Protein StabilityJournal of Biological Chemistry, 2004
- Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic miceOncogene, 2002
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993